Surfen

Overview

Surfen is a potent heparan sulfate antagonist. Surfen inhibits FGF2 binding and signal transduction. Surfen binds to glycosaminoglycans and reduces tau hyperphosphorylation. Surfen inhibits the activity of recombinant uronyl 2-O-sulfotransferase with an IC 50 of approximately 2 μM. Surfen inhibits HSV-1 viral infection . Surfen inhibits neural differentiation, delays remyelination, and alleviates EAE.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > HSV | Products > Signaling Pathways > Tau Protein

Product Information

• Catalog No.: HY-122704
• CAS No.: 3811-56-1
• Molecular Formula: C21H20N6O
• Molecular Weight: 372.42
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source